From India to the USA: HDFC ERGOs Guide to Why Travel Insurance is Essential
mumbai, India, Oct. 25, 2025 (GLOBE NEWSWIRE) -- A long flight, a…
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM),…
Flare Therapeutics Presents Part A Data from FX-909 Phase 1 Study at AACR-NCI-EORTC International Conference
October 24, 2025 12:00 ET | Source: Flare Therapeutics Inc. FX-909, the…
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
October 24, 2025 11:39 ET | Source: PMV Pharmaceuticals, Inc. Data presented…
Switching from Lead-Acid to Lithium Is Easier Than You Think. LiTime’s One-Stop Upgrade Solutions Empower RV, Marine, and Other Users to Go Lithium with Ease
Shenzhen, China , Oct. 23, 2025 (GLOBE NEWSWIRE) -- Have you ever…
Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes
LEHI, Utah, Oct. 23, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical…
ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors
SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation…
Padma Shri Rajinder Gupta, Emeritus Chairman of Trident Group, Elected Unopposed to Rajya Sabha from Punjab
State of Punjab and Nationally – Textile Sector to immensely benefit from…
LAS VEGAS TO WELCOME DIRECT, NONSTOP SERVICE FROM PARIS ON AIR FRANCE BEGINNING APRIL 15, 2026
Seasonal service to run through October 24, 2026Tickets on sale now at…
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology
Long-term continuous OGSIVEO treatment for up to 4 years was associated with…
